Product NDC: | 67457-190 |
Proprietary Name: | Enlon |
Non Proprietary Name: | edrophonium chloride |
Active Ingredient(s): | 10 mg/mL & nbsp; edrophonium chloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 67457-190 |
Labeler Name: | Mylan Institutional LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA088873 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130422 |
Package NDC: | 67457-190-15 |
Package Description: | 1 VIAL, GLASS in 1 CARTON (67457-190-15) > 15 mL in 1 VIAL, GLASS |
NDC Code | 67457-190-15 |
Proprietary Name | Enlon |
Package Description | 1 VIAL, GLASS in 1 CARTON (67457-190-15) > 15 mL in 1 VIAL, GLASS |
Product NDC | 67457-190 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | edrophonium chloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130422 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Institutional LLC |
Substance Name | EDROPHONIUM CHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |